Trial
NCT05605587
Leflunomide Treatment for MEN1 Patients - the LUMEN1 Trial
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University Hospital, Basel, Switzerland
Collaborators
—
Condition
MEN1 Gene Mutation
Intervention
Leflunomide 20 mg
Why stopped
The study was prematurely terminated due to significant difficulties in recruiting participants, arising from the extremely rare nature of the targeted gene mutation.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-27